Back to Search Start Over

Role of the IL33 and IL1RL1 pathway in the pathogenesis of Immunoglobulin A vasculitis

Authors :
Diana Prieto-Peña
Sara Remuzgo-Martínez
Fernanda Genre
Verónica Pulito-Cueto
Belén Atienza-Mateo
Javier Llorca
Belén Sevilla-Pérez
Norberto Ortego-Centeno
Ana Marquez
Leticia Lera-Gómez
María Teresa Leonardo
Ana Peñalba
Javier Narváez
Luis Martín-Penagos
Emilio Rodrigo
José A. Miranda-Filloy
Luis Caminal-Montero
Paz Collado
Javier Sánchez Pérez
Diego de Argila
Esteban Rubio
Manuel León Luque
Juan María Blanco-Madrigal
Eva Galíndez-Agirregoikoa
Oreste Gualillo
Javier Martín
Santos Castañeda
Ricardo Blanco
Miguel A. González-Gay
Raquel López-Mejías
Source :
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Publication Year :
2021
Publisher :
Nature Portfolio, 2021.

Abstract

Abstract Cytokines signalling pathway genes are crucial factors of the genetic network underlying the pathogenesis of Immunoglobulin-A vasculitis (IgAV), an inflammatory vascular condition. An influence of the interleukin (IL)33- IL1 receptor like (IL1RL)1 signalling pathway on the increased risk of several immune-mediated diseases has been described. Accordingly, we assessed whether the IL33-IL1RL1 pathway represents a novel genetic risk factor for IgAV. Three tag polymorphisms within IL33 (rs3939286, rs7025417 and rs7044343) and three within IL1RL1 (rs2310173, rs13015714 and rs2058660), that also were previously associated with several inflammatory diseases, were genotyped in 380 Caucasian IgAV patients and 845 matched healthy controls. No genotypes or alleles differences were observed between IgAV patients and controls when IL33 and IL1RL1 variants were analysed independently. Likewise, no statistically significant differences were found in IL33 or IL1RL1 genotype and allele frequencies when IgAV patients were stratified according to the age at disease onset or to the presence/absence of gastrointestinal (GI) or renal manifestations. Similar results were disclosed when IL33 and IL1RL1 haplotypes were compared between IgAV patients and controls and between IgAV patients stratified according to the clinical characteristics mentioned above. Our results suggest that the IL33-IL1RL1 signalling pathway does not contribute to the genetic network underlying IgAV.

Subjects

Subjects :
Medicine
Science

Details

Language :
English
ISSN :
20452322
Volume :
11
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Scientific Reports
Publication Type :
Academic Journal
Accession number :
edsdoj.4e5c12cf144c4687a3cac75fff04094d
Document Type :
article
Full Text :
https://doi.org/10.1038/s41598-021-95762-5